Skip to main content
. 2012 Apr;10(2):174–180. doi: 10.2450/2012.0034-11

Table I.

Characteristics of the patients and their grafts.

N. of patients 99
Sex (male/female) 48/51
Median age, years 46 (range 11–67)
Diagnosis
 Acute myeloid/lymphocytic leukaemia 38/15
 Chronic lymphocytic leukaemia 8
 CML/MDS 6/2
 NHL/HL 12/7
 Multiple myeloma 10
 Aplasia 1
Disease status (early/advanced) 66/33
Donor type (matched/mismatched) 84/15
Donor median age, years 41 (range 15–65)
Donor sex (male/female) 58/41
ABO compatibility (id/minor/major) 67/13/19
Cell source (BM/PB) 23/76
Conditioning (myeloablative/RIC) 48/51

Legend:

CML: chronic myeloid leukaemia; MDS: myelodysplastic syndrome; NHL: non-Hodgkin’s lymphoma; HL: Hodgkin’s lymphoma; BM: bone marrow; PB: peripheral blood; RIC: reduced intensity conditioning).